Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02348216
Title A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kite Pharma, Inc.
Indications

diffuse large B-cell lymphoma

follicular lymphoma

non-Hodgkin lymphoma

Therapies

axicabtagene ciloleucel

Age Groups: adult | senior
Covered Countries USA | FRA | DEU | CAN


No variant requirements are available.